Company intelligence / Profile preview

Vestal Laboratories

St. Louis, Missouri, USA

Ownership: Private
Development stage: Other

Overview

Vestal Laboratories was a specialized healthcare company focused on infection prevention and skin care products. Based in St. Louis, Missouri, the firm developed a wide range of germicides, surgical scrubs, and environmental disinfectants for use in clinical and laboratory settings. The company was acquired by Bristol-Myers Squibb in 1986 and later merged with Calgon's wound care division to form Calgon Vestal Laboratories. In 1996, Steris Corporation acquired the business for approximately $361 million, integrating Vestal's legacy brands into its infection prevention portfolio. Today, the products originally developed by Vestal, such as Vesphene and Septisol, remain staples in hospital hygiene and sterilization protocols.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Vestal Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vestal Laboratories.